CRT 2024

Discussion

Panel Moderator(s)

• 

  Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT

  Catheterization Laboratory Director & Deputy Head of Cardiology
  King Fahd Armed Forces Hospital
  Jeddah, Makkah, Saudi Arabia

  No relationships to disclose
• 

  Kimberly A. Skelding, MD, FACC FAHA FSCAI

  Division Chief of Cardiovascular Services
  RWJ Barnabas Health Jersey City
  Jersey City, New Jersey, United States

  No relationships to disclose

Panel Discussant(s)

• 

  J. Dawn Abbott, MD

  Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University
  Brown University
  Providence, Rhode Island, United States

  Disclosure information not submitted.
• 

  Nina Goodheart, MBA

  SVP & President
  Structural Heart & Aortic - Medtronic
  Doylestown, Pennsylvania, United States

  No relationships to disclose
• 

  Jennifer Jones-McMeans, PhD

  Divisional Vice President, Global Clinical Affairs
  Abbott Vascular, Inc.
  Santa Clara, California, United States

  Disclosure(s): Abbott Laboratories: Employee (Ongoing)
• 

  Tenley Koepnick

  Vice President, Global Clinical Affairs
  Edwards Lifesciences

  Disclosure(s): No financial relationships to disclose
• 

  Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC

  Professor of Medicine
  Yale School of Medicine
  New Haven, Connecticut, United States

  No relationships to disclose